Journavx Market Access Strategy in Focus: What ...

By Rene Pretorius

March 17, 2025

Vertex Pharmaceuticals’ Journavx, a non-opioid pain medication, received
Maternal Child Health in South Africa
Lenacapavir HIV Prevention: Approval and Access Strategy Updates
Strengthening Africa Health Partnership
Pharmacy Benefit Managers Report Reveals Escalating Drug Costs and Calls for ...
PEPFAR Funding Pause Threatens Global HIV Progress
Tariff Impact on Drugs: Navigating Challenges in the Generic and Biosimilar M...
The Urgent Need for Cancer Screening in South Africa
Evolving Cervical Cancer Treatment: Innovations and Challenges
Capvaxive Vaccine Approval
Cost-Effectiveness of Digital HIV Self-Testing
NICE Approves Gene Therapy for Sickle Cell: A Breakthrough in Treatment and H...
Cervical Cancer App: Enhancing Screening and Treatment